Sign in →

Test Code SPSA PSA Annual Screen 

Important Note

Medicare frequency limitations exist for this test in addition to diagnosis requirements. Click on link for list of medically necessary diagnoses: http://www.munsonhealthcare.org/medical-necessity. Click on link for Advance Beneficiary Notice of Noncoverage form: Advance Beneficiary Notice of Noncoverage

EHR Test Codes

  Test Code Test Name
Atlas SPSA PSA Annual Screen 
Cerner SPSA PSA Annual Screen 

 

Specimen Requirements

Preparation of Patient: 

None

 

Container Type: 

Gold Top SST Gel & Clot Activator Tube

Specimen Type:

Serum

 

Specimen Volume: 

1.0 mL of Serum minimum .5 mL of Serum

 

Specimen Handling/Transport:

Separate serum from cells within 2 hours of collection.

Transport refrigerated 2-8°C

 

Specimen Stability/Storage:

1 day refrigerated 2-8°C

>1 day frozen -20°C

Performing Laboratory

Munson Medical Center Laboratories

Chemistry Department

Priority, Frequency, & Turnaround

Priority:

Non-Emergent

 

Frequency:

24 hours 7 days a week

 

Turnaround:

0 - 1 days

Methodology

Chemiluminescent Immunoassay

Reporting

Reference Range: 

0 years to 41 years 0 - 2.7 ng/mL

41 years and up 0 - 4 ng/mL

 

Interpretive Data:

Testing performed by chemiluminescence on a Beckman Coulter DXI/Access platform. Results may not be comparable with tests performed on other manufacturer's methods or platforms.
 

Critical Decision: 

None

Clinical Significance

Prostate cancer is the second most common type of cancer found in men, occurring in 50% of them over 70. It is more successfully treated if diagnosed early.

 

An antigen has been identified that is specific for prostatic tissue. PSA is present in normal, benign hyperplastic and malignant prostatic tissue, in metastatic prostatic carcinoma and also prostatic fluid and seminal plasma.

 

Elevated serum PSA concentrations have been reported in patients with prostate cancer, benign prostatic hypertrophy, or inflammatory conditions and genitourinary tissue, but not in healthy men.

 

Serial measurement of PSA concentrations is important in monitoring patients with prostatic cancer and in determining the effectiveness of surgery or therapies.

CPT Code

G0103